The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors may have protective effects in the early stage of atherosclerosis in patients with type 2 diabetes, although similar effects in advanced atherosclerosis were not shown in recent randomized placebo-controlled studies. Therefore, we investigated th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cardiovasc Diabetol
Glavni autori: Kitao, Naoyuki, Miyoshi, Hideaki, Furumoto, Tomoo, Ono, Kota, Nomoto, Hiroshi, Miya, Aika, Yamamoto, Chiho, Inoue, Atsushi, Tsuchida, Kenichi, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Nakamura, Akinobu, Atsumi, Tatsuya
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634845/
https://ncbi.nlm.nih.gov/pubmed/29017497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0607-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items